Abstract
Patients with idiopathic Parkinson’s disease (IPD) have a reduced myocardial MIBG uptake in MIBG scintigraphy, indicating myocardial sympathetic denervation. We were interested whether this myocardial sympathetic denervation coincides with clinical symptoms of autonomic impairment in IPD patients. We performed MIBG scintigraphy, the SCOPA-AUT scale, a standardized medical history (developed in our clinic) and autonomic nervous system testing in 47 IPD patients (21 female, 26 male patients). We correlated myocardial MIBG uptake with the results of the SCOPA-AUT scale, the standardized medical history and the autonomic nervous system testing through the use of Spearman’s correlation. Myocardial MIBG uptake correlated significantly (p < 0.05) with several items of the SCOPA-AUT scale (in female patients: perspiration during the night, in male patients: sum score, saliva dribbling of the mouth, difficulty swallowing, fainting, constipation), of the standardized medical history (in male patients: swollen ankles) and of the autonomic nervous system testing (all patients: sum score, Ewing orthostasis test). Remarkably, we found more significant correlations in male than in female patients. Reduced myocardial sympathetic innervation—as revealed by MIBG scintigraphy—is associated with clinical symptoms of autonomic impairment. This association is more pronounced in male than in female patients. The cause for this gender-specific phenomenon is unclear.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Braune S (2001) The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res 11:351–355
Hirayama M, Hakusui S, Koike Y, Ito K, Kato T, Ikeda M et al (1995) A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst 53:230–234
Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y (2005) Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson’s disease. J Neurol Neurosurg Psychiatry 76:249–251
Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 67:189–194
Satoh A, Serita T, Tsujihata M (1997) Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson’s disease: assessment of cardiac sympathetic denervation. Nihon Rinsho 55:202–206
Sawada H, Oeda T, Yamamoto K, Kitagawa N, Mizuta E, Hosokawa R et al (2009) Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol 16:174–182
Spiegel J, Hellwig D, Farmakis G, Jost WH, Samnick S, Fassbender K et al (2007) Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson’s disease. Mov Disord 22:1004–1008
Taki J, Nakajima K, Hwang EH, Matsunari I, Komai K, Yoshita M et al (2000) Peripheral sympathetic dysfunction in patients with Parkinson’s disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 27:566–573
Yoshita M (1998) Differentiation of idiopathic Parkinson’s disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 155:60–67
Leńska-Mieciek M, Derecka-Charzyńska I, Fiszer U, Królicki L, Kułakowski P (2011) Syncope and autonomic cardiovascular dysfunction in Parkinson disease. Neurol Neurochir Pol 45:335–341
Manabe Y, Fujii D, Kono S, Sakai Y, Tanaka T, Narai H (2011) Systemic blood pressure profile correlates with cardiac 123I-MIBG uptake in patients with Parkinson’s disease. J Neurol Sci 307:153–156
Oka H, Toyoda C, Yogo M, Mochio S (2010) Olfactory dysfunction and cardiovascular dysautonomia in Parkinson’s disease. J Neurol 257:969–976
Nakamura T, Hirayama M, Yamashita F, Uchida K, Hama T, Watanabe H, Sobue G (2010) Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson’s disease. Mov Disord 25:1183–1189
Nakamura T, Hirayama M, Hara T, Hama T, Watanabe H, Sobue G (2011) Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson’s disease? Mov Disord 26:1869–1874
Haensch CA, Lerch H, Jörg J, Isenmann S (2009) Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson’s disease. Parkinsonism Relat Disord 15:134–137
Berganzo K, Tijero B, Somme JH, Llorens V, Sánchez-Manso JC, Low D et al (2012) SCOPA-AUT scale in different parkinsonism’s and its correlation with (123) I-MIBG cardiac scintigraphy. Parkinsonism Relat Disord 18:45–48
Visser M, Marinus J, Stiggelbout AM, van Hilton JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19:1306–1312
Hughes A, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P et al (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285–2293
Kim JS, Shim YS, Song IU, Yoo JY, Kim HT, Kim YI et al (2009) Cardiac sympathetic denervation and its association with cognitive deficits in Parkinson’s disease. Parkinsonism Relat Disord 15:706–708
Kitayama M, Wada-Isoe K, Irizawa Y, Nakashima K (2008) Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson’s disease. J Neurol Sci 264:22–26
Kashihara K, Ohno M, Katsu Y (2005) Psychoses in patients with Parkinson’s disease; their frequency, phenomenology, and clinical correlates. Rinsho Shinkeigaku 45:1–5
Oka H, Yoshioka M, Onouchi K, Morita M, Mochio S, Suzuki M et al (2007) Impaired cardiovascular autonomic function in Parkinson’s disease with visual hallucinations. Mov Disord 22:1510–1514
Nomura T, Inoue Y, Högl B, Uemura Y, Kitayama M, Abe T et al (2010) Relationship between (123)I-MIBG scintigrams and REM sleep behaviour disorder in Parkinson’s disease. Parkinsonism Relat Disord 16:683–685
Kim JS, Lee KS, Song IU, Kim YI, Kim SH, You IR et al (2008) Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms. J Neurol Sci 270:122–126
Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M et al (2004) Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci 220:105–111
Matsui H, Nishinaka K, Oda M, Komatsu K, Kubori T, Udaka F (2006) Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson’s disease correlate with major autonomic symptoms? Parkinsonism Relat Disord 12:284–288
Oka H, Toyoda C, Yogo M, Mochio S (2011) Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson’s disease. J Neural Transm 118:1323–1327
Shibata M, Morita Y, Shimizu T, Takahashi K, Suzuki N (2009) Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson’s disease. J Neurol Sci 276:79–83
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical standard
This single case study was performed in accordance with the ethical standard laid down in the 1964 Declaration of Helsinki.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guidez, D., Behnke, S., Halmer, R. et al. Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson’s disease?. J Neurol 261, 45–51 (2014). https://doi.org/10.1007/s00415-013-7135-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-013-7135-4